Bio-Path Holdings Inc
N/A
USD
N/A
N/A
...
Chart
Financials
Description
BPTH Company Description
Bio-Path Holdings Inc is a clinical and preclinical stage oncology-focused RNAi nanoparticle drug development company. It is engaged in utilizing a novel technology that achieves systemic delivery for target-specific protein inhibition for any gene product that is over-expressed in disease. The company's drug candidate, prexigebersen, is in the efficacy portion of Phase 2 clinical trial for acute myeloid leukemia (AML) in combination with low-dose cytarabine (LDAC) and combination with decitabine. The other drugs of the company are BP1002, BP1003, BP1001-A, and DNABILIZE.
BPTH Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view BPTH Smart Score
Score Breakdown
BPTH Company Description
Show More
Bio-Path Holdings Inc is a clinical and preclinical stage oncology-focused RNAi nanoparticle drug development company. It is engaged in utilizing a novel technology that achieves systemic delivery for target-specific protein inhibition for any gene product that is over-expressed in disease. The company's drug candidate, prexigebersen, is in the efficacy portion of Phase 2 clinical trial for acute myeloid leukemia (AML) in combination with low-dose cytarabine (LDAC) and combination with decitabine. The other drugs of the company are BP1002, BP1003, BP1001-A, and DNABILIZE. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of BPTH by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by BPTH's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on BPTH's company Twitter account
WallStreetBets
Number of mentions of BPTH in WallStreetBets Daily Discussion
BPTH News
Recent insights relating to BPTH
CNBC Recommendations
Recent picks made for BPTH stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in BPTH
Corporate Flights
Flights by private jets registered to BPTH
Our Analysis